cell therapies | pharmaphorum

Tuesday 21 July 2026

cell therapies

News

AstraZeneca buys cell therapy biotech for up to $1bn

AstraZeneca buys cell therapy biotech for up to $1bn

AstraZeneca plans to acquire Belgian in vivo cell therapy biotech EsoBiotec and has signed a pair of licensing deals with drug delivery firm Alteogen.

R&D

scale increase

Cell therapies are the future of healthcare, why are we stru...

The future of healthcare is undeniably heading toward cell therapies, as they offer hope for diseases where, to date, we have not been able to provide treatments or cures.

News

Martin Olin has been named chief executive of the UK start-up

UK biotech Swarm lands with a T-cell therapy mission

UK firm Swarm Oncology launches with a T-cell therapy platform to treat solid tumours, with a Resolution Therapeutics co-founder in the pilot seat.

News

Galapagos' chief executive Paul Stoffels

Galapagos unveils plan to split, hiving off its drugs unit

Belgian biotech Galapagos is mixing things up again via a plan to split in two, separating its drug development and cell therapy operations.

News

Illustration of gastric cancer cells

CARsgen gets a win for CAR-T in solid tumours

CARsgen Therapeutics' claudin 18.2-targeting autologous CAR-T therapy satri-cel has shown efficacy in gastric cancer, setting up a filing in China.

News

Heart from folded pages in a book

Capricor files cell therapy for DMD cardiomyopathy with FDA

Capricor completes its US filing for deramiocel, vying to become the first FDA-approved therapy for cardiomyopathy in Duchenne muscular dystrophy.